“…The triazole‐hydrazone (Rambabu et al, 2016), 1,2,3‐triazole‐silatrane (Singh et al, 2018), 1,2,3‐triazole‐nucleoside (Malkowski et al, 2017; Tachallait et al, 2018), 1,2,3‐triazole‐guanidine (Bakka et al, 2017), 1,2,3‐triazole‐biotin (Paparella et al, 2018), 1,2,3‐triazole‐betulin (Bębenek et al, 2017), and 1,2,3‐triazole‐pseudoaglycon (Szűcs et al, 2017) are the some other hybrids which possessed weak to moderate activities but were less active than the reference drugs.…”